Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Low zinc levels in chronic liver disease patients are linked to more severe symptoms like taste issues and skin problems, and zinc supplements might help.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Women with PCOS are much more likely to experience depression.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Finasteride and dutasteride can cause severe, lasting side effects.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Female pattern hair loss greatly affects women's quality of life, causing mild depression and anxiety, and increases medical expenses.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

New understanding and treatments for hair loss are improving, but more research is needed.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.